Remove Article
article thumbnail

TRAINING ARTICLE

Fierce Pharma

THIS IS WHERE THE TEXT OF THE ARTICLE WILL BE. | The introduction that will be displayed in the newsletter.

88
article thumbnail

January 31, 2023: New Article Suggests Moving From Idealism to Realism With Data Sharing

Rethinking Clinical Trials

For more, read the full article , and see the Living Textbook chapter on Data Sharing and Embedded Research. The post January 31, 2023: New Article Suggests Moving From Idealism to Realism With Data Sharing appeared first on Rethinking Clinical Trials.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

May 11, 2023: Article outlines key stakeholder insights related to participant data sharing in pragmatic trials

Rethinking Clinical Trials

A new article from the NIH Pragmatic Trials Collaboratory outlines stakeholder insights and ethical considerations related to sharing deidentified, participant-level data in pragmatic clinical trials. The article was published this month in Learning Health Systems. Read the full report.

Trials 130
article thumbnail

Cannes Lions, Ad Forum Spotlight The Chrysalis Initiative & EVERSANA Intouch in New Webinar, Article

Intouch Solutions

Recently, Ad Forum published an article highlighting five campaigns it found to be “ Raising the Bar for Health Equity in Advertising.” And, you can read the Ad Forum article here ! One was our ongoing work with The Chrysalis Initiative, a nonprofit working to eliminate racial disparities in breast cancer treatment.

Branding 105
article thumbnail

July 18, 2022: New Article Offers Recommendations for Pragmatic Trials in Emergency Medicine

Rethinking Clinical Trials

A new article in Academic Emergency Medicine fills the gap by providing recommendations for the design of PCTs in emergency settings. Read the full text of the article. The post July 18, 2022: New Article Offers Recommendations for Pragmatic Trials in Emergency Medicine appeared first on Rethinking Clinical Trials.

Medicine 130
article thumbnail

Digital Article: Immunophenotyping for targeted drug discovery

Drug Discovery World

A new digital article is now available to download entitled ‘ A comprehensive approach to immunophenotyping for targeted drug discovery and development’ With high costs of therapeutic development, success relies on optimising preclinical and early clinical studies.

Drugs 52
article thumbnail

Kris Kowdley, MD, Lead Author Published in NEJM Article

Velocity Clinical Research

Kris Kowdley, MD, AGAF, FAASLD, FACP, FACG , is the lead author of an article recently published in the New England Journal of Medicine. The article highlights the results of a Phase 3 trial of elafibranor for the treatment primary biliary cholangitis, an autoimmune disease that causes inflammation and damage of the bile ducts in the liver.